Implementation of Substance Use Treatment in Ambulatory Care

Assesses quality of life across physical, psychological, social, and environmental domains.

Offers a 5-item scale designed to measure global cognitive judgments of one's life satisfaction (not a measure of either positive or negative affect). Prompts participants to indicate how much they agree or disagree with each of the 5 items using a 7-point scale that ranges from 7 (strongly agree) to 1 (strongly disagree).

Provides a form for recording important information about prospective patients, including drug use history, treatment history, criminal history, and health history.

Provides a sample for buprenorphine treatment intake history and physical.

Includes a training algorithm that provides a detailed script of how a provider should conduct a brief intervention and referral to treatment, as well as a screening tool for alcohol and other drug use.

Provides a form that can be used when advocating with insurers about prior authorization process for buprenorphine.

Offers a sample checklist for treatment program personnel who answer inquiries about buprenorphine/naloxone treatment.

Lists activities that should be performed during followup appointments and behaviors that should be addressed with the patient.

Uses a 20-item instrument administered in an interview format to track behaviors characteristic of addiction related to prescription opioid medications in chronic pain populations. The instrument is scored based on participant responses, interviewer observations of displayed behaviors, and information gathered from medical chart review.

Provides a score indicating the severity of dependence on opioids using a 5-item questionnaire.